Baby care products: possible sources of infant phthalate exposure

Sheela Sathyanarayana1, Catherine J Karr, Paula Lozano

  • 1Department of Occupational and Environmental Health Sciences, Division of General Pediatrics, Child Health Institute, University of Washington, Building 296200, NE 74th St, Seattle, WA 98115-8160, USA. sathyana@u.washington.edu

Pediatrics
|February 5, 2008
PubMed

Insights

Infant exposure to phthalates from lotions, powders, and shampoos is common. Higher product use correlates with increased phthalate levels, especially in younger infants who are more vulnerable.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pediatrics

Background:

  • Phthalates are ubiquitous man-made chemicals with potential endocrine-disrupting effects.
  • Concerns exist regarding male reproductive development alterations due to phthalate exposure.
  • Infant exposure sources, particularly from personal care products, require further characterization.

Purpose of the Study:

  • To investigate the association between maternal-reported infant care product use and urinary phthalate metabolite concentrations in infants.
  • To identify specific infant care products linked to phthalate exposure.
  • To examine the impact of the number of products used on phthalate metabolite levels.

Main Methods:

  • Urine samples from 163 infants (born 2000-2005) were analyzed for 9 phthalate metabolites.
  • Infant exposure was defined by maternal reports of product use within 24 hours of urine collection.
  • Multiple linear regression and z-score standardization were used to analyze metabolite concentrations in exposed versus unexposed infants.

Main Results:

  • Over 80% of infants had detectable levels of 7 or more phthalate metabolites.
  • Exposure to lotion, powder, and shampoo significantly predicted higher concentrations of specific phthalate metabolites (monoethyl phthalate, monomethyl phthalate, monoisobutyl phthalate).
  • Increased numbers of products used were associated with higher phthalate metabolite concentrations, particularly in younger infants.

Conclusions:

  • Phthalate exposure in infants via common personal care products like lotions, powders, and shampoos is widespread and variable.
  • The number of products used directly correlates with increased infant phthalate metabolite levels.
  • Younger infants may be more susceptible to potential phthalate toxicity due to their developing systems and higher relative exposure.
Abstract

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bioplastics01:27

Bioplastics

Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Plasticizers01:31

Plasticizers

Water-reducers, or plasticizers, are chemical admixtures used in concrete to improve strength and workability. These additives reduce the water-cement ratio without compromising workability, lower the cement content while maintaining the same workability, or increase workability to assist concrete placement in inaccessible areas.
Plasticizers function by using surface-active agents to create repulsive electrostatic forces between cement particles. This dispersion enhances the concrete's...